Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07565090 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria expanded, about 26 words
    • Study description revised
    • Site details revised at 1 of 3 sites
  2. Recruitment opened
    • Start date changed from estimate of May 2026 to May 8, 2026
    • Site details revised at 3 of 3 sites
    v3
  3. Site contacts updated at 2 of 3 sitesv2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Clinical Study to Investigate the Safety and Immunogenicity of rVSV∆G-SUDV-GP, a Sudan Virus (SUDV) Vaccine for the Prevention of SUDV Disease in Adults in Good General Health.
Trial Details
NCT Number NCT07565090
Lead Sponsor International AIDS Vaccine Initiative
Collaborators: Biomedical Advanced Research and Development Authority
Conditions
(from sponsor)		 Sudan Virus Disease
Related terms Hemorrhagic Fever, Ebola, Hemorrhagic Fevers, Viral, Infections, Virus Diseases
Enrollment 112 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov